Date published: 2026-4-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ceramide Kinase Inhibitors

Ceramide kinase inhibitors represent a class of compounds specifically designed to modulate the activity of ceramide kinases, key enzymes involved in sphingolipid metabolism. Sphingolipids, including ceramides, play crucial roles in various cellular processes such as cell proliferation, apoptosis, and inflammation. Ceramide kinases, in particular, are responsible for catalyzing the phosphorylation of ceramides, converting them into ceramide-1-phosphate (C1P). This phosphorylation event has been implicated in diverse cellular signaling pathways, making ceramide kinases attractive targets for research and drug development. Inhibitors of ceramide kinases function by disrupting this enzymatic conversion, thereby influencing downstream signaling cascades associated with ceramide metabolism ceramide kinase inhibitors are diverse, reflecting the complex nature of the interactions between these small molecules and their enzymatic targets. Researchers have employed various synthetic strategies to design and optimize these inhibitors, aiming to enhance their selectivity and potency. Structural analyses of these compounds have revealed common motifs essential for their interaction with ceramide kinases, providing valuable insights for further refinement. The pharmacological modulation of ceramide kinases through these inhibitors presents a valuable approach for investigating the intricate roles of sphingolipid signaling in cellular physiology and pathology.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fingolimod

162359-55-9sc-507334
10 mg
$160.00
(0)

Fingolimod is a sphingosine-1-phosphate receptor modulator, capable of disrupting the sphingolipid metabolism, thereby indirectly impacting CERK's function.

NVP-231

362003-83-6sc-255397
5 mg
$115.00
(0)

NVP-231 functions as a ceramide kinase, engaging in the phosphorylation of ceramide to generate ceramide-1-phosphate. This process is crucial for regulating sphingolipid metabolism. The compound exhibits a unique affinity for the enzyme's active site, facilitating specific molecular interactions that stabilize the enzyme-substrate complex. Its kinetic behavior reveals a non-competitive inhibition pattern, allowing for nuanced control over ceramide signaling pathways and cellular responses.

D609

83373-60-8sc-201403
sc-201403A
5 mg
25 mg
$189.00
$575.00
7
(1)

D609 is a phosphatidylcholine-specific phospholipase C inhibitor, which can interfere with CERK by inhibiting ceramide production.

Myriocin (ISP-1)

35891-70-4sc-201397
10 mg
$150.00
8
(2)

Myriocin is a serine palmitoyltransferase inhibitor that can disrupt sphingolipid biosynthesis, indirectly inhibiting CERK.

D-erythro-Sphingosine

123-78-4sc-3546
sc-3546A
sc-3546B
sc-3546C
sc-3546D
sc-3546E
10 mg
25 mg
100 mg
1 g
5 g
10 g
$90.00
$194.00
$510.00
$2448.00
$9384.00
$15300.00
2
(2)

Sphingosine competes with ceramide, the substrate of CERK, leading to a decrease in CERK activity.

GW4869

6823-69-4sc-218578
sc-218578A
5 mg
25 mg
$203.00
$611.00
24
(3)

GW4869 is a neutral sphingomyelinase inhibitor, affecting the production of ceramide and thus indirectly influencing CERK.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporine A inhibits calcineurin, a protein phosphatase that can regulate ceramide metabolism and indirectly modulate CERK activity.

DL-PDMP

73257-80-4sc-201391
sc-201391B
sc-201391A
sc-201391C
10 mg
25 mg
50 mg
100 mg
$119.00
$273.00
$515.00
$837.00
3
(1)

PDMP inhibits glucosylceramide synthase, which can influence the balance of ceramide, thus indirectly affecting CERK.

Dihydro-D-erythro-Sphingosine

764-22-7sc-203911
10 mg
$77.00
(0)

Sphinganine is a competitive inhibitor of serine palmitoyltransferase, and can interfere with ceramide synthesis, thereby indirectly affecting CERK.

Imipramine

50-49-7sc-507545
5 mg
$190.00
(0)

Imipramine is an acid sphingomyelinase inhibitor, which can disrupt ceramide metabolism and indirectly inhibit CERK.